In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy targetXiaoqing Wang, X. Shirley Liu, Boning Zhang et al.|Cell|2021Cited by 200
TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy responseZexian Zeng, X. Shirley Liu, Cheryl J. Wong et al.|Nucleic Acids Research|2021Cited by 136
Systematic characterization of mutations altering protein degradation in human cancersCollin Tokheim, X. Shirley Liu, Xiaoqing Wang et al.|Molecular Cell|2021Cited by 89
<i>In Vivo</i> CRISPR Screens Identify E3 Ligase Cop1 as a Modulator of Macrophage Infiltration and Cancer Immunotherapy TargetXiaoqing Wang, X. Shirley Liu, Collin Tokheim et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 1
Abstract P108: In vivo CRISPR screens identify E3 ligase COP1 as a modulator of macrophage infiltration and cancer immunotherapy targetXiaoqing Wang, X. Shirley Liu, Collin Tokheim et al.|Molecular Cancer Therapeutics|2021Cited by 1